Gad, Ashraf
Mesilhy, Rowan
Maveli, Thomas
Ali, Fatima
Jasim, Noora
Adam, Malaz
Abdalla, Tasneim
Madani, Mohamed
Alkhateeb, Mohammad Ayman
Bayoumi, Mohammad A. A.
Article History
Received: 9 October 2024
Accepted: 15 July 2025
First Online: 22 July 2025
Declarations
:
: The authors declare no competing interests.
: This study was approved and received ethical approval by the Medical Research Centre (MRC)/Institutional Review Board (IRB) at Hamad Medical Corporation (HMC) under protocol number MRC-01-22-735. It was conducted following local legislation and institutional requirements. The study received no external funding, and informed consent was waived due to its retrospective nature. A waiver for the requirement of informed consent was granted by the Chair of the Medical Research Centre on the grounds of being a minimal risk study.
: Patients and/or the public were not involved in the design, conduct, reporting, or dissemination plans of this research.